Ignite Creation Date:
2024-05-06 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03637218
Status:
COMPLETED
Last Update Posted:
2020-01-07
First Post:
2018-07-09
Brief Title:
Acute Exposure of High Altitude on Cardiac Output
Sponsor:
University of Zurich
Organization:
University of Zurich
Study Overview
Official Title:
Acute Exposure of Simulated Hypoxia on Non-invasive Cardiac Output Assessments at Rest and During Exercise
Status:
COMPLETED
Status Verified Date:
2020-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Randomized crossover trial in patients with Pulmonary Hypertension PAH CTEPH to assess the acute response High Altitude Säntis 2500m above sea level on non-invasive cardiac output assessments by Finapres NOVA Technology at rest and under exercise
Detailed Description:
Low altitude baseline measurements will be performed in Zurich 460m asl including Echocardiography Right heart catheterization 6MWT pulmonary function test clinical assessment and blood gas Analysis
Randomly assigned to the order of testing the participants will be tested in Low Altitude Zurich 470m and at High Altitude 2500m
During the exposure High Altitude 2500m and Low Altitude Zurich 470m up to 5 hours the participants cardiac output non-invasively assessed will be measured repetitive during the whole intervention
Randomly assigned to the order of testing the participants will be tested in Low Altitude Zurich 470m and at High Altitude 2500m
During the exposure High Altitude 2500m and Low Altitude Zurich 470m up to 5 hours the participants cardiac output non-invasively assessed will be measured repetitive during the whole intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None